1. Home
  2. BBWI vs BLCO Comparison

BBWI vs BLCO Comparison

Compare BBWI & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBWI
  • BLCO
  • Stock Information
  • Founded
  • BBWI 1963
  • BLCO 1853
  • Country
  • BBWI United States
  • BLCO Canada
  • Employees
  • BBWI N/A
  • BLCO N/A
  • Industry
  • BBWI Clothing/Shoe/Accessory Stores
  • BLCO Ophthalmic Goods
  • Sector
  • BBWI Consumer Discretionary
  • BLCO Health Care
  • Exchange
  • BBWI Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • BBWI 5.0B
  • BLCO 5.2B
  • IPO Year
  • BBWI N/A
  • BLCO 2022
  • Fundamental
  • Price
  • BBWI $23.62
  • BLCO $14.98
  • Analyst Decision
  • BBWI Buy
  • BLCO Hold
  • Analyst Count
  • BBWI 17
  • BLCO 14
  • Target Price
  • BBWI $38.28
  • BLCO $16.46
  • AVG Volume (30 Days)
  • BBWI 5.6M
  • BLCO 490.8K
  • Earning Date
  • BBWI 11-24-2025
  • BLCO 10-29-2025
  • Dividend Yield
  • BBWI 3.39%
  • BLCO N/A
  • EPS Growth
  • BBWI N/A
  • BLCO N/A
  • EPS
  • BBWI 3.38
  • BLCO N/A
  • Revenue
  • BBWI $7,371,000,000.00
  • BLCO $4,976,000,000.00
  • Revenue This Year
  • BBWI $4.09
  • BLCO $8.29
  • Revenue Next Year
  • BBWI $2.75
  • BLCO $5.82
  • P/E Ratio
  • BBWI $6.97
  • BLCO N/A
  • Revenue Growth
  • BBWI N/A
  • BLCO 6.23
  • 52 Week Low
  • BBWI $23.40
  • BLCO $10.45
  • 52 Week High
  • BBWI $41.87
  • BLCO $20.71
  • Technical
  • Relative Strength Index (RSI)
  • BBWI 35.00
  • BLCO 48.04
  • Support Level
  • BBWI $23.49
  • BLCO $14.60
  • Resistance Level
  • BBWI $25.21
  • BLCO $16.00
  • Average True Range (ATR)
  • BBWI 0.88
  • BLCO 0.46
  • MACD
  • BBWI -0.20
  • BLCO -0.06
  • Stochastic Oscillator
  • BBWI 5.38
  • BLCO 27.14

About BBWI Bath & Body Works Inc.

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2024. For fiscal 2024, 76% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2023 levels, as consumer shopping patterns remained to normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like hair and laundry.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: